Dyspnea and Exercise Limitation in Mild COPD: The Value of CPET

Matthew D James, Kathryn M Milne, Devin B Phillips, J Alberto Neder, Denis E O'Donnell, Matthew D James, Kathryn M Milne, Devin B Phillips, J Alberto Neder, Denis E O'Donnell

Abstract

The majority of smokers with chronic obstructive pulmonary disease (COPD) have mild airflow limitation as determined by simple spirometry. Although small airway dysfunction is the hallmark of COPD, many studies attest to complex heterogeneous physiological impairments beyond increased airway resistance. These impairments are related to inflammation of lung parenchyma and its microvasculature, which is obscured by simple spirometry. Recent studies using advanced radiological imaging have highlighted significant structural abnormalities in smokers with relatively preserved spirometry. These important studies have generated considerable interest and have reinforced the pressing need to better understand the physiological consequences of various morphological abnormalities, and their impact on the clinical outcomes and natural history of COPD. The overarching objective of this review is to provide a concise overview of the importance and utility of cardiopulmonary exercise testing (CPET) in clinical and research settings. CPET uniquely allows evaluation of integrated abnormalities of the respiratory, cardio-circulatory, metabolic, peripheral muscle and neurosensory systems during increases in physiologic stress. This brief review examines the results of recent studies in mild COPD that have uncovered consistent derangements in pulmonary gas exchange and development of "restrictive" dynamic mechanics that together contribute to exercise intolerance. We examine the evidence that compensatory increases in inspiratory neural drive from respiratory control centers are required during exercise in mild COPD to maintain ventilation commensurate with increasing metabolic demand. The ultimate clinical consequences of this high inspiratory neural drive are earlier onset of critical respiratory mechanical constraints and increased perceived respiratory discomfort at relatively low exercise intensities.

Keywords: cardiopulmonary exercise testing; chronic obstructive pulmonary disease; dyspnea; gas exchange; neural drive; respiratory mechanics.

Copyright © 2020 James, Milne, Phillips, Neder and O'Donnell.

Figures

Figure 1
Figure 1
Ventilatory drive and respiratory mechanical response to exercise in patients with mild chronic obstructive pulmonary disease (COPD) compared to healthy controls. (A) The ratio of diaphragmatic electromyography (EMGdi) to maximal EMGdi (EMGdi,max) relative to work rate, (B) dyspnea intensity (measured by modified 10-point Borg scale) relative to the ratio of EMGdi/EMGdi,max (C) ventilation (VE) relative to the ratio of EMGdi/EMGdi,max (D) the ratio of transdiaphragmatic pressure (Pdi) relative to maximal Pdi (Pdi,max) relative to work rate (E) neuromechanical dissociation (represented as the ratio of EMGdi/EMGdi,max to Pdi/Pdi,max) relative to work rate (F) total work of breathing relative to work rate. Data are presented as Mean ± SEM. Triangles represent the tidal volume/minute ventilation inflection point. Reproduced with permission of the © ERS 2020: Guenette et al. (7).
Figure 2
Figure 2
Exertional dyspnea intensity (Borg scale; A), ventilation (B), ventilatory equivalent for carbon-dioxide (VE/VCO2; C), partial pressure of end-tidal CO2 (PETCO2; D), and oxygen saturation by pulse oximetry (SpO2; E); all for a given oxygen uptake during symptom-limited incremental cycle exercise in chronic obstructive pulmonary disease patients with normal single-breath diffusing capacity of the lung for carbon monoxide (DLCO; open symbols) and those with low DLCO (closed symbols) in the first tertile of forced expiratory volume in 1 s (FEV1). Tertile 1 (FEV1 > 73.5%predicted, square symbols). Data are means ± SE. *P < 0.05, normal vs. low DLCO.†P < 0.05, difference in dyspnea/oxygen uptake slope between normal and low DLCO. Elbehairy et al. (12).
Figure 3
Figure 3
(A–I) Proposed panel displays during interpretation of an incremental cardiopulmonary exercise test. Data showing selected perceptual, ventilatory control, dynamic respiratory mechanics, and breathing pattern response to incremental cycle exercise in patients with mild chronic obstructive pulmonary disease (COPD) and age-matched healthy controls. Data are presented as Mean ± SEM. VE/VCO2: ventilatory equivalent for carbon dioxide; IRV: inspiratory reserve volume; Fb: breathing frequency; PETCO2: partial pressure of end-tidal carbon dioxide; SpO2: arterial oxygen saturation measured by pulse oximetry; TLC: total lung capacity. *p < 0.05 mild COPD versus healthy controls at rest, at standardized work rates or at peak exercise. Adapted with permission of the American Thoracic Society. Copyright © 2020 American Thoracic Society. All rights reserved. Cite: Author(s)/Year/Title/Journal title/Volume/Pages. The American Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society. Readers are encouraged to read the entire article for the correct context at https://www.atsjournals.org/doi/full/10.1164/rccm.201211-1970OC The authors, editors, and The American Thoracic Society are not responsible for errors or omissions in adaptations.

References

    1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance–United States, 1971-2000. MMWR Surveill Summ. (2002) 51:1–16. Available online at:
    1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. (2007) 370:741–50. 10.1016/S0140-6736(07)61377-4
    1. Tilert T, Dillon C, Paulose-Ram R, Hnizdo E, Doney B. Estimating the US prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res. (2013) 14:103. 10.1186/1465-9921-14-103
    1. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, et al. . The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Int Med. (2005) 142:233–9. 10.7326/0003-4819-142-4-200502150-00005
    1. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. . An official American thoracic society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. (2012) 185:435–52. 10.1164/rccm.201111-2042ST
    1. Ofir D, Laveneziana P, Webb KA, Lam Y-M, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with gold stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (2008) 177:622–9. 10.1164/rccm.200707-1064OC
    1. Guenette JA, Chin RC, Cheng S, Dominelli PB, Raghavan N, Webb KA, et al. . Mechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPD. Eur Respir J. (2014) 44:1177–87. 10.1183/09031936.00034714
    1. Estepar RS, Kinney GL, Black-Shinn JL, Bowler RP, Kindlmann GL, Ross JC, et al. . Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. (2013) 188:231–9. 10.1164/rccm.201301-0162OC
    1. Kirby M, Owrangi A, Svenningsen S, Wheatley A, Coxson HO, Paterson NA, et al. . On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI. Thorax. (2013) 68:752–9. 10.1136/thoraxjnl-2012-203108
    1. Chin RC, Guenette JA, Cheng S, Raghavan N, Amornputtisathaporn N, Cortes-Telles A, et al. . Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am J Respir Crit Care Med. (2013) 187:1315–23. 10.1164/rccm.201211-1970OC
    1. Elbehairy AF, Ciavaglia CE, Webb KA, Guenette JA, Jensen D, Mourad SM, et al. . Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med. (2015) 191:1384–94. 10.1164/rccm.201501-0157OC
    1. Elbehairy AF, O'Donnell CD, Abd Elhameed A, Vincent SG, Milne KM, James MD, et al. . Low Resting diffusion capacity, dyspnea and exercise intolerance in COPD. J Appl Physiol. (2019) 127:1107–16. 10.1152/japplphysiol.00341.2019
    1. Jones NL. The Ins And Outs of Breathing: How We Learnt About the Body's Most Vital Function. Bloomington, IN: iUniverse Publishing; (2011).
    1. Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in normal subjects. J Clin Invest. (1969) 48:564–73. 10.1172/JCI106015
    1. Jolley CJ, Luo YM, Steier J, Reilly C, Seymour J, Lunt A, et al. . Neural respiratory drive in healthy subjects and in COPD. Eur Respir J. (2009) 33:289–97. 10.1183/09031936.00093408
    1. Bradley TD, Chartrand DA, Fitting JW, Killian KJ, Grassino A. The relation of inspiratory effort sensation to fatiguing patterns of the diaphragm. Am Rev Respir Dis. (1986) 134:1119–24.
    1. Means JH. Dyspnea. in Medical Monograph. 5th ed. Baltimore, MD: Williams & Wilkins; (1924).
    1. Jolley CJ, Luo YM, Steier J, Rafferty GF, Polkey MI, Moxham J. Neural respiratory drive and breathlessness in COPD. Eur Respir J. (2015) 45:355–64. 10.1183/09031936.00063014
    1. Faisal A, Alghamdi BJ, Ciavaglia CE, Elbehairy AF, Webb KA, Ora J, et al. . Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med. (2016) 193:299–309. 10.1164/rccm.201504-0841OC
    1. O'Donnell DE, Ora J, Webb KA, Laveneziana P, Jensen D. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol. (2009) 167:116–32. 10.1016/j.resp.2009.01.010
    1. Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, Roca J, Barbera JA, Wagner PD. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol. (2009) 106:1902–8. 10.1152/japplphysiol.00085.2009
    1. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, et al. . Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med. (2010) 181:270–8. 10.1164/rccm.200907-0988OC
    1. Hueper K, Vogel-Claussen J, Parikh MA, Austin JH, Bluemke DA, Carr J, et al. . Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD study. Am J Respir Crit Care Med. (2015) 192:570–80. 10.1164/rccm.201411-2120OC
    1. Tedjasaputra V, van Diepen S, Phillips DB, Wong EYL, Bhutani M, Michaelchuk WW, et al. . Pulmonary capillary blood volume response to exercise is diminished in mild chronic obstructive pulmonary disease. Respir Med. (2018) 145:57–65. 10.1016/j.rmed.2018.10.015
    1. Ross BA, Brotto AR, Fuhr DP, Phillips DB, van Diepen S, Bryan TL, et al. . The supine position improves but does not normalize the blunted pulmonary capillary blood volume response to exercise in mild COPD. J Appl Physiol. (2020) 128:925–33. 10.1152/japplphysiol.00890.2019
    1. Vogel-Claussen J, Schönfeld C-O, Kaireit TF, Voskrebenzev A, Czerner CP, Renne J, et al. . Effect of indacaterol/glycopyrronium on pulmonary perfusion and ventilation in hyperinflated COPD patients (CLAIM): a double-blind, randomised, crossover trial. Am J Respir Crit Care Med. (2019) 199:1086–96. 10.1164/rccm.201805-0995OC
    1. Behnia M, Wheatley C, Avolio A, Johnson B. Influence of resting lung diffusion on exercise capacity in patients with COPD. BMC Pulm Med. (2017) 17:117. 10.1186/s12890-017-0454-y
    1. Neder JA, Berton DC, Muller PT, O'Donnell DE. Incorporating lung diffusing capacity for carbon monoxide in clinical decision making in chest medicine. Clin Chest Med. (2019) 40:285–305. 10.1016/j.ccm.2019.02.005
    1. Barberà JA, Riverola A, Roca J, Ramirez J, Wagner PD, Ros D, et al. . Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (1994) 149:423–9. 10.1164/ajrccm.149.2.8306040
    1. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest. (2005) 128:2025–34. 10.1378/chest.128.4.2025
    1. Ward SA, Whipp BJ. Kinetics of the ventilatory and metabolic responses to moderate-intensity exercise in humans following prior exercise-induced metabolic acidaemia. New Front Respir Control. (2009) 669:323–6. 10.1007/978-1-4419-5692-7_66
    1. Rocha A, Arbex FF, Sperandio PA, Souza A, Biazzim L, Mancuso F, et al. . Excess ventilation in chronic obstructive pulmonary disease-heart failure overlap. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med. (2017) 196:1264. 10.1164/rccm.201704-0675OC
    1. Caviedes IR, Delgado I, Soto R. Ventilatory inefficiency as a limiting factor for exercise in patients with COPD. Respir Care. (2012) 57:583–9. 10.4187/respcare.01342
    1. Moreira MA, Medeiros GA, Boeno FP, Sanches PR, Silva Junior DP, Muller AF. Oxygen desaturation during the six-minute walk test in COPD patients. J Bras Pneumol. (2014) 40:222–8. 10.1590/S1806-37132014000300004
    1. Andrianopoulos V, Franssen FM, Peeters JP, Ubachs TJ, Bukari H, Groenen M, et al. . Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia. Respir Physiol Neurobiol. (2014) 190:40–6. 10.1016/j.resp.2013.10.002
    1. Neder JA, Arbex FF, Alencar MC, O'Donnell CD, Cory J, Webb KA, et al. . Exercise ventilatory inefficiency in mild to end-stage COPD. Eur Respir J. (2015) 45:377–87. 10.1183/09031936.00135514
    1. Patessio A, Casaburi R, Carone M, Appendini L, Donner CF, Wasserman K. Comparison of gas exchange, lactate, and lactic acidosis thresholds in patients with chronic obstructive pulmonary disease. Am RevRespir Dis. (1993) 148:622–6. 10.1164/ajrccm/148.3.622
    1. Saey D, Debigare R, LeBlanc P, Mador MJ, Cote CH, Jobin J, et al. . Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (2003) 168:425–30. 10.1164/rccm.200208-856OC
    1. Aaron CP, Hoffman EA, Lima JAC, Kawut SM, Bertoni AG, Vogel-Claussen J, et al. . Pulmonary vascular volume, impaired left ventricular filling and dyspnea: the MESA lung study. PLoS ONE. (2017) 12:e0176180. 10.1371/journal.pone.0176180
    1. Haouzi P. Venous pressure and dyspnea on exertion in cardiac failure: was Tinsley Randolph Harrison right? Respir Physiol Neurobiol. (2009) 167:101–6. 10.1016/j.resp.2008.09.001
    1. Haarmann H, Folle J, Nguyen XP, Herrmann P, Heusser K, Hasenfuß G, et al. . Sympathetic activation is associated with exercise limitation in COPD. COPD J Chronic Obstruct Pulm Dis. (2016) 13:589–94. 10.3109/15412555.2015.1136272
    1. Phillips DB, Steinback CD, Collins SE, Fuhr DP, Bryan TL, Wong EYL, et al. . The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease. J Physiol. (2018) 596:3233–44. 10.1113/JP275762
    1. Elbehairy AF, Guenette JA, Faisal A, Ciavaglia CE, Webb KA, Jensen D, et al. . Mechanisms of exertional dyspnoea in symptomatic smokers without COPD. Eur Respir J. (2016) 48:694–705. 10.1183/13993003.00077-2016
    1. O'Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. (2006) 3:180–4. 10.1513/pats.200508-093DO
    1. Stubbing DG, Pengelly LD, Morse JLC, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol. (1980) 49:511–5. 10.1152/jappl.1980.49.3.511
    1. Dodd DS, Brancatisano T, Engel LA. Chest wall mechanics during exercise in patients with severe chronic air-flow obstruction. Am Rev Respir Dis. (1984) 129:33–8.
    1. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med. (1991) 325:917–23. 10.1056/NEJM199109263251304
    1. O'Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol. (2006) 101:1025–35. 10.1152/japplphysiol.01470.2005
    1. Guenette JA, Chin RC, Cory JM, Webb KA, O'Donnell DE. Inspiratory capacity during exercise: measurement, analysis, and interpretation. PulmMed. (2013) 2013:956081. 10.1155/2013/956081
    1. O'Donnell DE, Guenette JA, Maltais F, Webb KA. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest. (2012) 141:753–62. 10.1378/chest.11-0787
    1. Laveneziana P, Webb KA, Ora J, Wadell K, O'Donnell DE. Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints. Am J Respir Crit Care Med. (2011) 184:1367–73. 10.1164/rccm.201106-1128OC
    1. O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax. (2009) 64:216–23. 10.1136/thx.2008.103598
    1. O'Donnell DE, Maltais F, Porszasz J, Webb KA, Albers FC, Deng Q, et al. . The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial. PLoS One. (2014) 9:e96574. 10.1371/journal.pone.0096574
    1. Elbehairy AF, Webb KA, Laveneziana P, Domnik NJ, Neder JA, O'Donnell DE. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD. Respir physiol Neurobiol. (2018) 252–253:64–71. 10.1016/j.resp.2018.03.012
    1. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. (1984) 85:751–8. 10.1378/chest.85.6.751
    1. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. (1988) 93:580–6. 10.1378/chest.93.3.580
    1. Roig M, Eng JJ, MacIntyre DL, Road JD, Reid WD. Deficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary disease. J Cardio Pulm Rehabil Prev. (2011) 31:120–4. 10.1097/HCR.0b013e3181f68ae4
    1. Neder JA, Berton DC, Muller PT, Elbehairy AF, Rocha A, Palange P, et al. . Ventilatory inefficiency and exertional dyspnea in early chronic obstructive pulmonary disease. Ann Am Thorac Soc. (2017) 14:S22–9. 10.1513/AnnalsATS.201612-1033FR
    1. Ciavaglia CE, Guenette JA, Langer D, Webb KA, Alberto NJ, O'Donnell DE. Differences in respiratory muscle activity during cycling and walking do not influence dyspnea perception in obese patients with COPD. J Appl Physiol. (2014) 117:1292–301. 10.1152/japplphysiol.00502.2014
    1. Ora J, Laveneziana P, Wadell K, Preston M, Webb KA, O'Donnell DE. Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol. (2011) 111:10–9. 10.1152/japplphysiol.01131.2010
    1. Neder JA, Milne KM, Berton DC, de-Torres JP, Jensen D, Tan WC, et al. . Exercise tolerance according to the definition of airflow obstruction in smokers. Am J Respir Crit Care Med. 10.1164/rccm.202002-0298LE. [Epub ahead of print].

Source: PubMed

3
S'abonner